SequelSEC

Rezolute, Inc. RZLT

Pharmaceutical Preparations · CIK 0001509261 · Fiscal year ends 0630

AnnualQuarterlyTTM
Revenue
Unavailable
Fiscal year ended 2026-06-30
Operating income
-$21.56M
Fiscal year ended 2026-06-30
Free cash flow
Unavailable
Fiscal year ended 2026-06-30

Valuation, from the filing

Public float$258.83MMarket value of stock held by non-affiliates, as stated on the cover page for 2024-12-31
Float per share$2.85Float divided by shares outstanding in the same filing. A floor under the share price on that date, not the price itself.
Float / equity1.6×A lower bound on the multiple, because affiliate holdings are excluded.

Every figure here is drawn from the 10-K cover page and the statements behind it, so each one traces to a filing. Public float counts only stock held by non-affiliates, which makes these floors rather than estimates: a high multiple is conclusive, a low one may mean cheap or may mean closely held. The float was measured on 2024-12-31, not today, and each multiple below it uses the figures for the fiscal year ending 2025-06-30 — the year that filing covered.

How this compares in its industry

Percentile among the Pharmaceutical Preparations filers on this site, highest value first. A high percentile means a large figure, which is good for a margin and not for leverage — the ranking says where the company sits, not whether that is where it should be.

MeasureReportedPercentile
Current ratio9.68x89th

Rezolute, Inc. (RZLT) reported net income of -$20.49M for the fiscal year ended 2026-06-30. This page shows 10 annual periods of income statement, balance sheet and cash flow figures normalized from Rezolute, Inc.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Pharmaceutical Preparations.

Income

Rezolute, Inc. income by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-302024-03-31
RevenueUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Cost of revenueUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Gross profitUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Operating income-$21.56M-$17.37M-$24.22M-$19.82MUnavailable-$20.02M-$17.08M-$16.94MUnavailable-$16.21M
Net income-$20.49M-$16.17M-$22.77M-$18.15MUnavailable-$18.91M-$15.73M-$15.38MUnavailable-$17.05M
Research & development$14.89M$11.41M$14.35M$13.15MUnavailable$15.28M$12.63M$12.75MUnavailable$12.40M
Weighted-average diluted sharesUnavailableshares 104.04Mshares 103.69Mshares 103.42MUnavailableshares 70.03Mshares 69.94Mshares 69.74MUnavailableshares 50.81M
Pretax incomeUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Income tax expenseUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Diluted EPSUnavailable$-0.16$-0.22$-0.18Unavailable$-0.27$-0.22$-0.22Unavailable$-0.34
Selling, general & administrativeUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
General & administrative$6.67M$5.95M$9.87M$6.67MUnavailable$4.74M$4.45M$4.19MUnavailable$3.81M
Selling & marketingUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable

Balance

Rezolute, Inc. balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-302024-03-31
Cash & equivalents$10.62M$11.24M$11.94M$9.10MUnavailable$14.60M$8.93M$10.47MUnavailable$5.93M
Total assets$112.85M$125.46M$138.63M$158.66MUnavailable$94.74M$112.01M$123.41MUnavailable$87.74M
Current assets$110.51M$122.05M$135.11M$154.71MUnavailable$88.74M$98.69M$110.18MUnavailable$82.21M
Total liabilities$12.16M$8.62M$10.63M$11.50MUnavailable$12.17M$12.42M$9.97MUnavailable$16.88M
Current liabilities$11.42M$7.70M$9.53M$10.21MUnavailable$10.53M$10.61M$7.99MUnavailable$6.96M
Total equity incl. NCI$100.69M$116.83M$128.00M$147.17MUnavailable$82.57M$99.59M$113.44MUnavailable$70.86M
Temporary (mezzanine) equityUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
InventoryUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Accounts receivableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
GoodwillUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Long-term debtUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Accounts payable$5.03M$3.20M$3.78M$3.26MUnavailable$6.50M$3.15M$2.18MUnavailable$3.50M

Cash flow

Rezolute, Inc. cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-302024-03-31
Operating cash flow-$13.15M-$13.74M-$20.32M-$17.43MUnavailable-$17.40M-$13.67M-$16.01MUnavailable-$15.24M
Capital expendituresUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Investing cash flow$12.30M$12.28M$22.81M-$68.49MUnavailable$23.05M$11.47M-$49.41MUnavailable$8.67M
Financing cash flow$227.00K$747.00K$356.00K$911.00KUnavailable$10.00K$657.00K$5.50MUnavailable-$3.00K
Net change in cash-$621.00K-$708.00K$2.85M-$85.01MUnavailable$5.66M-$1.54M-$59.92MUnavailable-$6.57M
Stock-based compensation$4.10M$4.42M$3.41M$2.53MUnavailable$1.90M$1.44M$1.40MUnavailable$1.90M
Common dividends paidUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Common share repurchasesUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Depreciation & amortization$8.00K$8.00K$7.00K$8.00KUnavailable$7.00K$8.00K$8.00KUnavailable$9.00K

Derived

Rezolute, Inc. derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-302024-03-31
Free cash flowUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Gross marginUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Operating marginUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
FCF marginUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
SBC / revenueUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Current ratio9.68x15.84x14.18x15.15xUnavailable8.43x9.30x13.79xUnavailable11.82x
Revenue YoY growthUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Net marginUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
R&D / revenueUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
CapEx / revenueUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Long-term debt / equityUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Effective tax rateUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open RZLT in the interactive workspace to inspect any figure back to its filing.

Source filings

10-K · Filed 2026-09-24View SEC filing
10-Q · Filed 2026-05-12View SEC filing
10-Q · Filed 2026-02-12View SEC filing
10-Q · Filed 2025-11-06View SEC filing
10-K · Filed 2025-09-17View SEC filing
10-Q · Filed 2025-05-13View SEC filing

Companies in the same industry

AAGH AARD ABBV ABCL ABEO ABT ABUS ABVC ACAD ACET ACRS ACRV

Reconciliation checks needing review

6 periods on this page do not reconcile under this site’s normalization. Read that as a limitation here before an observation about the company: the figures are the filer’s own, the filings linked above are authoritative, and a difference usually means the concepts this site selected do not match how this filer presents its statements. Nothing is adjusted to make a check pass.

gross profit bridgeinconsistent2025-06-30

Withheld: cost revenue, revenue could not be reconciled with the rest of this filer’s statement.

balance equationinconsistent2025-06-30

Withheld: assets, equity, liabilities could not be reconciled with the rest of this filer’s statement.

balance equationinconsistent2024-06-30

Withheld: assets, equity, liabilities could not be reconciled with the rest of this filer’s statement.

gross profit bridgeinconsistent2024-06-30

Withheld: cost revenue, revenue could not be reconciled with the rest of this filer’s statement.

balance equationinconsistent2023-06-30

Withheld: assets, equity, liabilities could not be reconciled with the rest of this filer’s statement.

gross profit bridgeinconsistent2023-06-30

Withheld: cost revenue, revenue could not be reconciled with the rest of this filer’s statement.